Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 16;14(2):255.
doi: 10.3390/life14020255.

An Emerging Role of Micro- and Nanoplastics in Vascular Diseases

Seung Eun Lee  1 , Hyun Kyung Yoon  2 , Do Yun Kim  2 , Taek Seung Jeong  2 , Yong Seek Park  1
Affiliations
Review

An Emerging Role of Micro- and Nanoplastics in Vascular Diseases

Seung Eun Lee et al. Life (Basel). .

Abstract

Vascular diseases are the leading causes of death worldwide, and they are attributable to multiple pathologies, such as atherosclerosis, diabetes, and chronic obstructive pulmonary disease. Exposure to various environmental contaminants is associated with the development of various diseases, including vascular diseases. Among environmental contaminants, micro- and nanoplastics have gained attention as global environmental risk factors that threaten human health. Recently, extensive research has been conducted on the effects of micro- and nanoplastics on various human diseases, including vascular diseases. In this review, we highlight the effects of micro- and nanoplastics on vascular diseases.

Keywords: environmental contaminants; micro- and nanoplastics; toxicity; vascular diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The fate of micro- and nanoplastics in mammalian bodies.
Figure 2
Figure 2
Sources of micro- and nanoplastics in the environment.
Figure 3
Figure 3
The possible influence of micro- and nanoplastics on the vascular system.
See this image and copyright information in PMC

References

    1. Lyle A.N., Taylor W.R. The pathophysiological basis of vascular disease. Lab. Invest. 2019;99:284–289. doi: 10.1038/s41374-019-0192-2. - DOI - PubMed
    1. Tesfamariam B., DeFelice A.F. Endothelial injury in the initiation and progression of vascular disorders. Vascul. Pharmacol. 2007;46:229–237. doi: 10.1016/j.vph.2006.11.005. - DOI - PubMed
    1. Abdellatif M., Bugger H., Kroemer G., Sedej S. NAD(+) and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities. J. Lipid Atheroscler. 2022;11:111–132. doi: 10.12997/jla.2022.11.2.111. - DOI - PMC - PubMed
    1. Jeong S.J., Oh G.T. Unbalanced Redox With Autophagy in Cardiovascular Disease. J. Lipid Atheroscler. 2023;12:132–151. doi: 10.12997/jla.2023.12.2.132. - DOI - PMC - PubMed
    1. Woo S.H., Kim D.Y., Choi J.H. Roles of Vascular Smooth Muscle Cells in Atherosclerotic Calcification. J. Lipid Atheroscler. 2023;12:106–118. doi: 10.12997/jla.2023.12.2.106. - DOI - PMC - PubMed

LinkOut - more resources